3,4-dihydro-2H-1,5-benzodioxepin-7-ylmethylamine → HCID 118113914, compound

HRID 918844Notes

Reaction equation

HRID 918844 reaction equation
[O:1]1[CH2:7][CH2:6][CH2:5][O:4][C:3]2[CH:8]=[C:9]([CH2:12][NH2:13])[CH:10]=[CH:11][C:2]1=2.[Br:14][C:15]1[CH:16]=[CH:17][C:18]2[N:19]([CH:21]=[C:22]([C:24](OCC)=[O:25])[N:23]=2)[CH:20]=1>>[Br:14][C:15]1[CH:16]=[CH:17][C:18]2[N:19]([CH:21]=[C:22]([C:24]([NH:13][CH2:12][C:9]3[CH:10]=[CH:11][C:2]4[O:1][CH2:7][CH2:6][CH2:5][O:4][C:3]=4[CH:8]=3)=[O:25])[N:23]=2)[CH:20]=1

Participants

3

Reactant 2

HCID 27952953,4-dihydro-2H-1,5-benzodioxepin-7-ylmethylamineHCID 7141939Ethyl 6-bromoimidazo[1,2-a]pyridine-2-carboxylate

Product 1

HCID 118113914HCID 118113914, compound

Procedure

The title compound was prepared by essentially following the same procedures described for Intermediate I, using (3,4-dihydro-2H-benzo[b][1,4]dioxepin-7-yl)methanamine and ethyl 6-bromoimidazo[1,2-a]pyridine-2-carboxylate as starting materials.

Sources & evidence

ORD record
ord-abd02e89de774ad0af8caf0d39fce101
Source dataset
uspto-grants-2016_03
Patent number
US09271969B2

Reaction notes

Loading…